Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
about
Is the cardiovascular system a therapeutic target for cannabidiol?Role of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationAn organotypic slice model for ex vivo study of neural, immune, and microbial interactions of mouse intestineModulation of gut-specific mechanisms by chronic δ(9)-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: a systems biology analysis.Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?Cannabidiol changes P-gp and BCRP expression in trophoblast cell linesThe therapeutic potential of the endocannabinoid system for Alzheimer's disease.Cannabidiol in inflammatory bowel diseases: a brief overview.Neuroanatomy of lower gastrointestinal pain disordersPhytochemicals and their potential usefulness in inflammatory bowel disease.An update on PPAR activation by cannabinoids.Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.Medical cannabis: Another piece in the mosaic of autoimmunity?Cannabinoids decrease the th17 inflammatory autoimmune phenotype.The antiprotozoal drug pentamidine ameliorates experimentally induced acute colitis in miceClinical studies and anti-inflammatory mechanisms of treatments.Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells.Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques.Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model.
P2860
Q26865370-D076FC0A-AC96-4F43-9EF9-8D4A1C20A24BQ30357558-CD1B4264-26C6-473E-BB4A-C4A006B5F708Q30712453-606892A9-B764-465E-BD4A-02FDAC72FB29Q33713868-1E3D33CC-6DF1-43C0-AEA1-299818BD38D1Q35613040-BFB80BC8-89EE-4AD9-B4D0-E6BAA52A5105Q36729404-20F774DB-1023-4C56-9AA2-C426463A17B5Q37178591-A83ADA2E-D5F3-4FD6-A8A6-2B8676C0F165Q37997020-C96DCACB-1461-4D98-AD85-3345F62181D4Q38027809-66B8D32E-D924-418A-91C2-D45DC3C499FAQ38191576-F16D1EDE-FC4F-45E2-A974-E94D5EC7999FQ38312093-DB571030-B0FB-437C-8E2E-DA92A3B6DD3DQ38808034-2002206F-D5BB-4471-8552-353019E18345Q38918638-2CD254DE-8184-426D-AAB9-6B42D666BD60Q38937293-6F633103-A395-406C-84A4-BF361884C930Q39012168-0945D262-7A23-4A9C-9912-DC59042C8BBDQ39119286-B8C235A9-ED28-4C94-ACD6-74E1D07373ABQ42117982-D5B6C761-B9B2-4AB2-BABA-3C3250FCB5FDQ47124754-DAA5FCC8-794B-4C36-AAE0-D5F97BED0AFDQ47143965-A6A0CC95-44AC-4CC6-960D-EAAD14386C53Q48353765-AABCEBCC-DEF3-4EEA-8F31-CA2FFE3CE69FQ51743312-4C2E5B74-F864-4D8F-96D5-0FEA5859A37AQ55379948-E31D698A-0941-4BAF-B003-D88C059C0E84
P2860
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
@ast
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
@en
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
@nl
type
label
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
@ast
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
@en
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
@nl
prefLabel
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
@ast
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
@en
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
@nl
P2093
P2860
P50
P921
P1433
P1476
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
@en
P2093
Carla Cirillo
Daniele De Filippis
Joris G De Man
Teresa Iuvone
P2860
P304
P356
10.1371/JOURNAL.PONE.0028159
P407
P50
P577
2011-01-01T00:00:00Z